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作用蛋白 3（RIP3）是导致 TNF 诱导下两株细胞选择不同死亡方式的主因，RIP3
是 TNF 诱导的细胞凋亡与细胞坏死相互转换的分子开关。RIP3 不会影响 RIP1
介导的细胞凋亡，但却是 RIP1 介导的细胞坏死所必需的，同时 caspase 的广谱性




























Cell death has been subdivided into the morphologically distinct processes of 
apoptosis and necrosis. Apoptosis is the process of programmed cell death, while 
necrosis is a form of traumatic cell death that occurs under a variety of physological 
and pathological conditions. Despite of the belief that necrosis might also be mediated 
by some programs, it is still a challenge to characterize the precise mechanisms 
underlying programmed necrosis and the molecular switches between apoptosis and 
necrosis.  
Tumor necrosis factor (TNF) can trigger different types of cell death in two 
NIH-3T3 cell lines which are derived from the same cell origin. By using the 
approaches of genetics and molecular biology, we have identified receptor-interacting 
protein 3 (RIP3) as the main cause of the different cell death, and found that RIP3 is a 
molecular switch between TNF-induced apoptosis and necrosis in NIH-3T3 cells. 
RIP3 does not affect RIP1-mediated apoptosis but is required for RIP1-mediated 
necrosis and that is further enhanced by pan caspase inhibitor zVAD. RIP3 is also 
responsible for necrosis in other cells. 
We have further revealed that RIP3 can regulate cellular energy metabolism 
which affects necrotic cell death. RIP3 interacts with and enhances key enzymes of 
metabolic pathway——PYGL (glycogen phosphorylase), GLUL (glutamate-ammonia 
ligase), and GLUD1 (glutamate dehydrogenase 1). These increase cellular energy 
metabolism level and reactive oxygen species (ROS) from mitochondrial respiration 
chain that partially accounts for RIP3’s ability to promote necrosis. 
In this study, we have found RIP3 functions as the molecular switch between 
apoptosis and necrosis. We have also revealed that RIP3 mediates necrosis at least 
partly through increasing energy metabolism-associated ROS production. Our 














necrosis-related diseases. Since deletion of RIP3 can improve the condition of acute 
pancreatitis in a mouse model, RIP3 could become a potential drug target for these 
diseases. 
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